By Gil Bashe – Artificial intelligence was impossible to miss at HLTH Europe in Amsterdam. It appeared on the main stage, throughout the agenda, across the exhibition floor, and dominated conversations among providers, researchers, investors, entrepreneurs, and policymakers.
Read More
Now on demand, Health Unabashed episode with host Gil Bashe and guest Ritesh Patel, Chief Growth Officer at Doceree, and one of health technology’s most respected global advisors. They explore the forces reshaping healthcare: AI’s rapid shift from clinical promise to operational reality, the collapse of traditional medical publishing, & much more.
Now on demand, Health Unabashed episodes with guest Matthew Zachary, Founder of Stupid Cancer. Part 1 highlights Healthcare’s Broken Trust: Autonomy, Anger, and Advocacy and Part 2, The Insurance Maze: Patient Autonomy in a Profit-Driven System. Take a listen!
By Gil Bashe – India is fast evolving from an investment market into a strategic partner where policy, digital infrastructure and scientific scale reshape the global geography of health innovation.
By Gil Bashe – When I discuss Healing the Sick Care System: Why People Matter with audiences, I expect nods of recognition acknowledging the mess and the hopelessness so many experience within today’s health system. I anticipate questions about what to do next and how to navigate a system that often feels stacked against both patients and professionals.
As we embark on another year of changes and advancements, we asked them, what major event, transformation, or innovation in 2025 had a lasting impact on healthcare, whether positive or negative, and is likely to shape its future trajectory? Here is what they had to say.
Our 2025 Countdown Continues! #9 from Health UnaBASHEd and HealthLaw HotSpot. Follow us until the end of the year for our reveal of the top 10 played episodes from the radio and from the podcast network on Healthcare NOW Radio.
By Gil Bashe – At the HIMSS AI in Healthcare Forum, the energy was palpable, and the audience quiet and focused. This wasn’t a tech demo or a sales pitch. It was a gathering of health sector stewards—leaders seeking clarity amid the fog of anticipated disruption.
Now on demand, Health Unabashed episode with guest, former acting CEO of Global Genes and founder/CEO of the Orphan Therapeutics Accelerator Craig Martin, who discusses the urgent need to rescue clinically promising drugs for rare and ultra-rare diseases.